Skip to main content
Fig. 4 | Clinical Epigenetics

Fig. 4

From: Detection and monitoring of hypermethylated RASSF1A in serum from patients with metastatic breast cancer

Fig. 4

Correlation between the concentrations of the protein tumor markers and hypermethylated RASSF1A based on the cross-sectional samples from each of the 24 patients. The serum concentration of CA 15-3 (a), CEA (b), and TPA (c) are plotted against the average hypermethylated RASSF1A concentration determined by using all six primer designs. The data was obtained from 24 serum samples collected from patients with metastatic breast cancer

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us